This Anagliptin API CAS:739366-20-2 is a pharmaceuticadrus for the treatment of type 2 diabetes mellitus. It is approved for use in Japan. The product belongs to the class of anti-diabetic drues known as dipeptidyl peptidase-4 inhibitors. It is a white to yellow crystalline powder. The product' s purity is high, and its stability is good. Anagliptin has a positive effect on low density lipoprotein levels and is effective in assisting the treatment of type 2 diabetes
This Anagliptin API CAS:739366-20-2 has a broad medical market value. Since we have perfect production quality system, advanced equipment and rigorous scientific research attitude. The quality of the products is excellent and our company can offer long-term supply to you. If you are interested, please feel free to contact us and we will offer you the best service.